Nature Metrics Limited 09243907 false 2024-01-01 2024-12-31 2024-12-31 2024-12-31 The principal activity of the company is environmental consulting, biotechnology research and development. Digita Accounts Production Advanced 6.30.9574.0 true true true false false false 09243907 2024-01-01 2024-12-31 09243907 2024-12-31 09243907 bus:Director11 bus:Consolidated 2024-12-31 09243907 bus:Director4 bus:Consolidated 2024-12-31 09243907 bus:Director9 bus:Consolidated 2024-12-31 09243907 bus:OrdinaryShareClass1 bus:Consolidated 2024-12-31 09243907 bus:OrdinaryShareClass2 bus:Consolidated 2024-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2024-12-31 09243907 bus:Consolidated 2024-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2024-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2024-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2024-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-12-31 09243907 core:ShareCapital 2024-12-31 09243907 core:ShareCapital bus:Consolidated 2024-12-31 09243907 core:SharePremium 2024-12-31 09243907 core:SharePremium bus:Consolidated 2024-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-12-31 09243907 core:FinanceLeases core:CurrentFinancialInstruments 2024-12-31 09243907 core:FinanceLeases core:CurrentFinancialInstruments bus:Consolidated 2024-12-31 09243907 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2024-12-31 09243907 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments bus:Consolidated 2024-12-31 09243907 core:CurrentFinancialInstruments 2024-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 2024-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2024-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2 2024-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear 2 2024-12-31 09243907 core:Non-currentFinancialInstruments 2024-12-31 09243907 core:Non-currentFinancialInstruments bus:Consolidated 2024-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2024-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2024-12-31 09243907 core:BetweenTwoFiveYears 2024-12-31 09243907 core:BetweenTwoFiveYears bus:Consolidated 2024-12-31 09243907 core:MoreThanFiveYears 2024-12-31 09243907 core:MoreThanFiveYears bus:Consolidated 2024-12-31 09243907 core:WithinOneYear 2024-12-31 09243907 core:WithinOneYear bus:Consolidated 2024-12-31 09243907 core:FurnitureFittingsToolsEquipment 2024-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-12-31 09243907 core:OtherPropertyPlantEquipment 2024-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2024-12-31 09243907 core:OtherProvisionsContingentLiabilities 2024-12-31 09243907 core:OtherProvisionsContingentLiabilities bus:Consolidated 2024-12-31 09243907 core:Share-basedArrangement1 bus:Consolidated 2024-12-31 09243907 bus:FRS102 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Audited bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:FullAccounts bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:RegisteredOffice bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:CompanySecretary1 2024-01-01 2024-12-31 09243907 bus:Director1 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Director10 2024-01-01 2024-12-31 09243907 bus:Director10 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Director11 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Director3 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Director4 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Director5 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Director9 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:OrdinaryShareClass1 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:OrdinaryShareClass2 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:Consolidated 1 2024-01-01 2024-12-31 09243907 bus:PrivateLimitedCompanyLtd bus:Consolidated 2024-01-01 2024-12-31 09243907 bus:ConsolidatedGroupCompanyAccounts 2024-01-01 2024-12-31 09243907 1 2024-01-01 2024-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2024-01-01 2024-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2024-01-01 2024-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-01-01 2024-12-31 09243907 core:ShareCapital 2024-01-01 2024-12-31 09243907 core:ShareCapital bus:Consolidated 2024-01-01 2024-12-31 09243907 core:SharePremium 2024-01-01 2024-12-31 09243907 core:SharePremium bus:Consolidated 2024-01-01 2024-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-01-01 2024-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar 2024-01-01 2024-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2024-01-01 2024-12-31 09243907 core:FurnitureFittings bus:Consolidated 2024-01-01 2024-12-31 09243907 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-01-01 2024-12-31 09243907 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2024-01-01 2024-12-31 09243907 core:Share-basedArrangement1 bus:Consolidated 2024-01-01 2024-12-31 09243907 core:Subsidiary1 2024-01-01 2024-12-31 09243907 core:Subsidiary1 1 2024-01-01 2024-12-31 09243907 core:UKTax bus:Consolidated 2024-01-01 2024-12-31 09243907 countries:EnglandWales bus:Consolidated 2024-01-01 2024-12-31 09243907 2023-12-31 09243907 bus:Consolidated 2023-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2023-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2023-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2023-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2023-12-31 09243907 core:ShareCapital 2023-12-31 09243907 core:ShareCapital bus:Consolidated 2023-12-31 09243907 core:SharePremium 2023-12-31 09243907 core:SharePremium bus:Consolidated 2023-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2023-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2023-12-31 09243907 core:CostValuation 2023-12-31 09243907 core:FurnitureFittingsToolsEquipment 2023-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2023-12-31 09243907 core:OtherPropertyPlantEquipment 2023-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2023-12-31 09243907 core:OtherProvisionsContingentLiabilities 2023-12-31 09243907 core:OtherProvisionsContingentLiabilities bus:Consolidated 2023-12-31 09243907 core:Share-basedArrangement1 bus:Consolidated 2023-12-31 09243907 2023-01-01 2023-12-31 09243907 2023-12-31 09243907 bus:OrdinaryShareClass1 bus:Consolidated 2023-12-31 09243907 bus:OrdinaryShareClass2 bus:Consolidated 2023-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2023-12-31 09243907 bus:Consolidated 2023-12-31 09243907 core:FinanceLeases core:CurrentFinancialInstruments 2023-12-31 09243907 core:FinanceLeases core:CurrentFinancialInstruments bus:Consolidated 2023-12-31 09243907 core:CurrentFinancialInstruments 2023-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 2023-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2023-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2 2023-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear 2 2023-12-31 09243907 core:Non-currentFinancialInstruments 2023-12-31 09243907 core:Non-currentFinancialInstruments bus:Consolidated 2023-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2023-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2023-12-31 09243907 core:BetweenTwoFiveYears 2023-12-31 09243907 core:BetweenTwoFiveYears bus:Consolidated 2023-12-31 09243907 core:MoreThanFiveYears 2023-12-31 09243907 core:MoreThanFiveYears bus:Consolidated 2023-12-31 09243907 core:WithinOneYear 2023-12-31 09243907 core:WithinOneYear bus:Consolidated 2023-12-31 09243907 core:FurnitureFittingsToolsEquipment 2023-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2023-12-31 09243907 core:OtherPropertyPlantEquipment 2023-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2023-12-31 09243907 core:Share-basedArrangement1 bus:Consolidated 2023-12-31 09243907 bus:Consolidated 2023-01-01 2023-12-31 09243907 bus:Consolidated 1 2023-01-01 2023-12-31 09243907 1 2023-01-01 2023-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2023-01-01 2023-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2023-01-01 2023-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2023-01-01 2023-12-31 09243907 core:ShareCapital 2023-01-01 2023-12-31 09243907 core:ShareCapital bus:Consolidated 2023-01-01 2023-12-31 09243907 core:SharePremium 2023-01-01 2023-12-31 09243907 core:SharePremium bus:Consolidated 2023-01-01 2023-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2023-01-01 2023-12-31 09243907 core:Share-basedArrangement1 bus:Consolidated 2023-01-01 2023-12-31 09243907 core:Subsidiary1 1 2023-01-01 2023-12-31 09243907 core:UKTax bus:Consolidated 2023-01-01 2023-12-31 09243907 2022-12-31 09243907 bus:Consolidated 2022-12-31 09243907 bus:Consolidated core:PreviouslyStatedAmount 2022-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2022-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated core:PreviouslyStatedAmount 2022-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2022-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated core:PreviouslyStatedAmount 2022-12-31 09243907 core:ShareCapital 2022-12-31 09243907 core:ShareCapital bus:Consolidated core:PreviouslyStatedAmount 2022-12-31 09243907 core:SharePremium 2022-12-31 09243907 core:SharePremium bus:Consolidated core:PreviouslyStatedAmount 2022-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated core:PreviouslyStatedAmount 2022-12-31 09243907 core:Share-basedArrangement1 bus:Consolidated 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09243907

Nature Metrics Limited

Annual Report and Consolidated Financial Statements

for the Year Ended 31 December 2024

 

Nature Metrics Limited

Contents

Company Information

1

Strategic Report

2

Directors' Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Consolidated Profit and Loss Account

8

Consolidated Statement of Comprehensive Income

9

Consolidated Balance Sheet

10

Balance Sheet

11

Consolidated Statement of Changes in Equity

12

Statement of Changes in Equity

13

Consolidated Statement of Cash Flows

14

Statement of Cash Flows

15

Notes to the Financial Statements

16 to 34

Detailed Consolidated Profit and Loss Account

35 to 37

Detailed Company Profit and Loss Account

38 to 40

 

Nature Metrics Limited

Company Information

Directors

Dr C Bruce

Mr R Ellis

Mr N C Von Luttichau Jolck

Ms D Patel

Mr G Bassetti

Company secretary

Dr J Jones

Registered office

1 Occam Court
Surrey Research Park
Guildford
Surrey
GU2 7HJ

Auditors

Metric Accountants Limited
Level 30, The Leadenhall Building
122 Leadenhall Street
London
EC3V 4AB

 

Nature Metrics Limited

Strategic Report for the Year Ended 31 December 2024

The directors present their strategic report for the year ended 31 December 2024.

Principal activity

The principal activity of the group is environmental consulting, biotechnology research and development.

Fair review of the business

The Group results for the year were:
Operating loss of £9,618,361 (2023: £9,257,476)
Loss before taxation of £9,674,610 (2023: £9,218,277)
Net cash decrease of £4,403,139 (2023: £965,251 increase)

The Company results for the year were:
Operating loss of £8,989,192 (2023: £8,389,780)
Loss before taxation of £8,995,454 (2023: £8,349,606)
Net cash decrease of £4,458,156 (2023: £957,482 increase)

In arriving at these results the Board has given careful consideration to the management of the Group's financial resources, in particular cashflow management to maximise financial performance.

As at 31 December 2024, the Group's net cash balance was £3,102,367 (2023: £7,505,506).
As at 31 December 2024, the Company's net cash balance was £2,970,920 (2023: £7,429,076).

The Directors use a range of KPIs and other metrics to measure performance of the business. The key ones are detailed below:

The group's key financial and other performance indicators during the year were as follows:

Financial KPIs

Unit

2024

2023

Gross Profit Margin

%

51

46

Turnover

£

5,335,672

5,670,059

Principal risks and uncertainties

The principal risk for the business is the potential for ongoing operating losses; however, this has been mitigated by the successful fundraising completed during the year, which has strengthened the Company's financial position. Inflationary pressures impacting the general economic climate continue to be a risk to the Group's activities. While this inflationary pressure is particularly central on fuel and food, it leads to general uncertainty and caution. To date, the group has not been adversely affected in demand for its products and services.

Changes in foreign currency exchange movements are a risk to any global business. The Group manages the risk of foreign exchange losses through regional cash flow forecasting and monthly balance sheet reviews.

The Group holds no publicly listed investments and as such it is not exposed to the risk factors posed by the stock market.

Approved by the Board on 26 September 2025 and signed on its behalf by:

.........................................
Ms D Patel
Director

   
     
 

Nature Metrics Limited

Directors' Report for the Year Ended 31 December 2024

The directors present their report and the for the year ended 31 December 2024.

Directors of the group

The directors who held office during the year were as follows:

Dr C Bruce

Mr R Ellis

Mr J Schrieber (ceased 26 January 2024)

Mr N C Von Luttichau Jolck

Mr I Davies (ceased 2 August 2024)

Ms D Patel

Mr G Bassetti (appointed 23 December 2024)

Going concern

During the year the Group made losses before tax of £9,674,610 and management forecast that the Group will continue to be loss making in the short-term future. As at 31 December 2024 the Group had a cash balance of £3,102,367.

In December 2024 the Group received legal commitments for future equity funding of £20,072,104. £3,572,112 was received before 31 December 2024 as a convertible loan note. £16,499,992 was received after 31 December 2024.

The current Group cash balance as of 31 July 2025 was £13,579,868, and due to the strong cash position the Board are confident that the Group will be able to meet its liabilities as they fall due for a period of not less than 12 months from the signing of the Balance Sheet.

Disclosure of information to the auditor

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditor is unaware.

Reappointment of auditors

In accordance with section 485 of the Companies Act 2006, a resolution for the re-appointment of Metric Accountants Limited as auditors of the company is to be proposed at the forthcoming Annual General Meeting.

Approved by the Board on 26 September 2025 and signed on its behalf by:

.........................................
Ms D Patel
Director

   
     
 

Nature Metrics Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and the company and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group's and the company's transactions and disclose with reasonable accuracy at any time the financial position of the group and the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Nature Metrics Limited

Independent Auditor's Report to the Members of Nature Metrics Limited

Opinion

We have audited the financial statements of Nature Metrics Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024, which comprise the Consolidated Profit and Loss Account, Consolidated Statement of Comprehensive Income, Consolidated Balance Sheet, Balance Sheet, Consolidated Statement of Changes in Equity, Statement of Changes in Equity, Consolidated Statement of Cash Flows, Statement of Cash Flows, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2024 and of the group's loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Nature Metrics Limited

Independent Auditor's Report to the Members of Nature Metrics Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

the parent company financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Nature Metrics Limited

Independent Auditor's Report to the Members of Nature Metrics Limited

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the financial statements, including how fraud may occur by enquiring of management of its own consideration of fraud. In particular, we looked at where management made subjective judgements, for example in respect of significant accounting estimates that involved making assumptions and considering future events that are inherently uncertain. We reviewed and tested the key estimates and judgements made by management.

We gained an understanding of the legal and regulatory framework applicable to the Group and the industry in which it operates, drawing on our broad sector experience, and considered the risk of acts by the Group that were contrary to these laws and regulations, including fraud. We focused on laws and regulations that could give rise to a material misstatement in the financial statements, including the Companies Act 2006 and UK tax legislation.

We made enquiries of management with regards to compliance with the above laws and regulations and corroborated any necessary evidence to relevant information, for example, minutes of meetings and correspondence, including legal correspondence.

Our tests included agreeing the financial statements disclosures to underlying supporting documentation and enquiries with management.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion.

There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
James Richardson (Senior Statutory Auditor)
For and on behalf of Metric Accountants Limited, Statutory Auditor

Level 30, The Leadenhall Building
122 Leadenhall Street
London
EC3V 4AB

26 September 2025

 

Nature Metrics Limited

Consolidated Profit and Loss Account for the Year Ended 31 December 2024

Note

2024
£

2023
£

Turnover

3

5,335,672

5,670,059

Cost of sales

 

(2,626,842)

(3,044,602)

Gross profit

 

2,708,830

2,625,457

Administrative expenses

 

(12,405,221)

(11,936,995)

Other operating income

78,030

54,062

Operating loss

4

(9,618,361)

(9,257,476)

Other interest receivable and similar income

5

90,208

118,052

Interest payable and similar expenses

6

(146,457)

(78,853)

   

(56,249)

39,199

Loss before tax

 

(9,674,610)

(9,218,277)

Tax on loss

10

383,439

201,789

Loss for the financial year

 

(9,291,171)

(9,016,488)

Profit/(loss) attributable to:

 

Owners of the company

 

(9,291,171)

(9,016,488)

The group has no recognised gains or losses for the year other than the results above.

 

Nature Metrics Limited

Consolidated Statement of Comprehensive Income for the Year Ended 31 December 2024

2024
£

2023
£

Loss for the year

(9,291,171)

(9,016,488)

Total comprehensive income for the year

(9,291,171)

(9,016,488)

Total comprehensive income attributable to:

Owners of the company

(9,291,171)

(9,016,488)

 

Nature Metrics Limited

(Registration number: 09243907)
Consolidated Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

11

51,741

58,821

Tangible assets

12

1,178,697

1,990,657

Debtors

16

155,672

159,777

Other financial assets

14

186,138

186,138

 

1,572,248

2,395,393

Current assets

 

Stocks

15

430,262

612,125

Debtors

16

2,376,704

2,795,060

Cash at bank and in hand

17

3,102,367

7,505,506

 

5,909,333

10,912,691

Creditors: Amounts falling due within one year

18

(6,714,504)

(3,433,377)

Net current (liabilities)/assets

 

(805,171)

7,479,314

Total assets less current liabilities

 

767,077

9,874,707

Provisions for liabilities

21

(274,256)

(274,256)

Net assets

 

492,821

9,600,451

Capital and reserves

 

Called up share capital

23

7

7

Share premium reserve

30,482,533

30,686,605

Other reserves

24

442,691

55,078

Retained earnings

(30,432,410)

(21,141,239)

Equity attributable to owners of the company

 

492,821

9,600,451

Shareholders' funds

 

492,821

9,600,451

Approved and authorised by the Board on 26 September 2025 and signed on its behalf by:
 

.........................................
Ms D Patel
Director

 

Nature Metrics Limited

(Registration number: 09243907)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

11

51,741

58,821

Tangible assets

12

833,283

1,249,521

Investments

13

1

1

Debtors

16

155,672

159,777

Other financial assets

14

186,138

186,138

 

1,226,835

1,654,258

Current assets

 

Stocks

15

399,645

528,299

Debtors

16

4,922,280

5,048,246

Cash at bank and in hand

 

2,970,920

7,429,076

 

8,292,845

13,005,621

Creditors: Amounts falling due within one year

18

(6,524,908)

(3,236,633)

Net current assets

 

1,767,937

9,768,988

Total assets less current liabilities

 

2,994,772

11,423,246

Provisions for liabilities

21

(274,256)

(274,256)

Net assets

 

2,720,516

11,148,990

Capital and reserves

 

Called up share capital

23

7

7

Share premium reserve

30,482,533

30,686,605

Other reserves

24

442,691

55,078

Retained earnings

(28,204,715)

(19,592,700)

Shareholders' funds

 

2,720,516

11,148,990

The company made a loss after tax for the financial year of £8,612,015 (2023 - loss of £8,147,817).

Approved and authorised by the Board on 26 September 2025 and signed on its behalf by:
 

.........................................
Ms D Patel
Director

   
     
 

Nature Metrics Limited

Consolidated Statement of Changes in Equity for the Year Ended 31 December 2024
Equity attributable to the parent company

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

Total equity
£

At 1 January 2024

7

30,686,605

55,078

(21,141,239)

9,600,451

9,600,451

Loss for the year

-

-

-

(9,291,171)

(9,291,171)

(9,291,171)

Share transaction costs

-

(204,072)

-

-

(204,072)

(204,072)

Other movements on reserves

-

-

387,613

-

387,613

387,613

At 31 December 2024

7

30,482,533

442,691

(30,432,410)

492,821

492,821

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

Total equity
£

At 1 January 2023

5

21,055,538

37,129

(12,124,751)

8,967,921

8,967,921

Loss for the year

-

-

-

(9,016,488)

(9,016,488)

(9,016,488)

New share capital subscribed

2

9,631,067

-

-

9,631,069

9,631,069

Other movements on reserves

-

-

17,949

-

17,949

17,949

At 31 December 2023

7

30,686,605

55,078

(21,141,239)

9,600,451

9,600,451

 

Nature Metrics Limited

Statement of Changes in Equity for the Year Ended 31 December 2024

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

At 1 January 2024

7

30,686,605

55,078

(19,592,700)

11,148,990

Loss for the year

-

-

-

(8,612,015)

(8,612,015)

Share transaction costs

-

(204,072)

-

-

(204,072)

Other movements on reserves

-

-

387,613

-

387,613

At 31 December 2024

7

30,482,533

442,691

(28,204,715)

2,720,516

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

At 1 January 2023

5

21,055,538

37,129

(11,444,883)

9,647,789

Loss for the year

-

-

-

(8,147,817)

(8,147,817)

New share capital subscribed

2

9,631,067

-

-

9,631,069

Other movements on reserves

-

-

17,949

-

17,949

At 31 December 2023

7

30,686,605

55,078

(19,592,700)

11,148,990

 

Nature Metrics Limited

Consolidated Statement of Cash Flows for the Year Ended 31 December 2024

Note

2024
£

2023
£

Cash flows from operating activities

Loss for the year

 

(9,291,171)

(9,016,488)

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

4

891,496

965,036

Profit on disposal of tangible assets

(8,818)

(8,935)

Finance income

5

(90,208)

(118,052)

Finance costs

6

81,098

17,878

Share based payment transactions

 

387,613

17,949

Income tax expense

10

(383,439)

(201,789)

 

(8,413,429)

(8,344,401)

Working capital adjustments

 

Decrease/(increase) in stocks

15

181,863

(184,041)

Decrease/(increase) in trade and other debtors

16

637,882

(733,762)

Decrease in trade and other creditors

18

(100,173)

(203,257)

Increase in provisions

21

-

274,256

(Decrease)/increase in deferred income

 

(46,542)

280,033

Cash generated from operations

 

(7,740,399)

(8,911,172)

Income taxes received

10

191,853

140,426

Net cash flow from operating activities

 

(7,548,546)

(8,770,746)

Cash flows from investing activities

 

Interest received

90,208

118,052

Acquisitions of tangible assets

(99,813)

(100,992)

Proceeds from sale of tangible assets

 

12,340

8,935

Net cash flows from investing activities

 

2,735

25,995

Cash flows from financing activities

 

Interest paid

6

(81,098)

(17,878)

Proceeds from issue of ordinary shares, net of issue costs

 

(204,072)

9,631,069

Proceeds from bank borrowing draw downs

 

(7,310)

(43,862)

Proceeds from issue of convertible debt, net of issue costs

 

3,572,111

-

Payments to finance lease creditors

 

(136,959)

140,673

Net cash flows from financing activities

 

3,142,672

9,710,002

Net (decrease)/increase in cash and cash equivalents

 

(4,403,139)

965,251

Cash and cash equivalents at 1 January

 

7,505,506

6,540,255

Cash and cash equivalents at 31 December

 

3,102,367

7,505,506

 

Nature Metrics Limited

Statement of Cash Flows for the Year Ended 31 December 2024

Note

2024
£

2023
£

Cash flows from operating activities

Loss for the year

 

(8,612,015)

(8,147,817)

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

4

523,130

585,695

Finance income

(90,208)

(117,141)

Finance costs

81,098

18,742

Share based payment transactions

 

387,613

17,949

Income tax expense

10

(383,439)

(201,789)

 

(8,093,821)

(7,844,361)

Working capital adjustments

 

Decrease/(increase) in stocks

15

128,654

(131,035)

Decrease/(increase) in trade and other debtors

16

321,657

(1,264,320)

Decrease in trade and other creditors

18

(35,108)

(238,105)

Increase in provisions

21

-

274,256

(Decrease)/increase in deferred income

 

(104,459)

288,349

Cash generated from operations

 

(7,783,077)

(8,915,216)

Income taxes received

10

191,853

140,426

Net cash flow from operating activities

 

(7,591,224)

(8,774,790)

Cash flows from investing activities

 

Interest received

90,208

117,141

Acquisitions of tangible assets

(99,812)

(94,007)

Net cash flows from investing activities

 

(9,604)

23,134

Cash flows from financing activities

 

Interest paid

(81,098)

(18,742)

Proceeds from issue of ordinary shares, net of issue costs

 

(204,072)

9,631,069

Proceeds from bank borrowing draw downs

 

(7,310)

(43,862)

Proceeds from issue of convertible debt, net of issue costs

 

3,572,111

-

Payments to finance lease creditors

 

(136,959)

140,673

Net cash flows from financing activities

 

3,142,672

9,709,138

Net (decrease)/increase in cash and cash equivalents

 

(4,458,156)

957,482

Cash and cash equivalents at 1 January

 

7,429,076

6,471,594

Cash and cash equivalents at 31 December

 

2,970,920

7,429,076

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
1 Occam Court
Surrey Research Park
Guildford
Surrey
GU2 7HJ

These financial statements were authorised for issue by the Board on 26 September 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Basis of consolidation

The consolidated financial statements consolidate the financial statements of the company and its subsidiary undertakings drawn up to 31 December 2024.

A subsidiary is an entity controlled by the company. Control is achieved where the company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

The results of subsidiaries acquired or disposed of during the year are included in the Profit and Loss Account from the effective date of acquisition or up to the effective date of disposal, as appropriate. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by the group.

The purchase method of accounting is used to account for business combinations that result in the acquisition of subsidiaries by the group. The cost of a business combination is measured as the fair value of the assets given, equity instruments issued and liabilities incurred or assumed at the date of exchange, plus costs directly attributable to the business combination. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Any excess of the cost of the business combination over the acquirer’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities recognised is recorded as goodwill.

Inter-company transactions, balances and unrealised gains on transactions between the company and its subsidiaries, which are related parties, are eliminated in full. Intra-group losses are also eliminated but may indicate an impairment that requires recognition in the consolidated financial statements.

Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the group.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Judgements

In the application of the accounting policies the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis.
 

Key sources of estimation uncertainty

The key areas of estimation uncertainty have been considered by management, being:
- Tangible fixed assets
Tangible fixed assets are depreciated over their useful lives. The actual lives of the assets are assessed annually and may vary depending on the number of factors. In assessing asset lives, factors such as technological innovation, product life cycle and maintenance programmes are taken into account.
- Share options
The assessment of value of the share options granted to employees and key individuals involved with the Company.
- Tax losses
The assessed likelihood that the Company will be able to utilise previously recorded tax losses against future taxable profits.
- Accruals and prepayments
The estimates applied to determine accruals and prepayments in respect of sales revenue and expenses.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Revenue from the sale of goods is recognised when all the following conditions are met:
- The Group has transferred the significant risks and rewards of the ownership to the buyer;
- The Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
- The amount can be reliably measured;
- It is probable that the Group will receive the consideration due under the transaction; and
- All revenue from contracts to provide services are recognised over the period in which the services are provided.

Revenue is recognised in line with the stage of completion as at the balance sheet date.

Government grants

The company receives government grants in the accounting period. These grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the group operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

36 months and 120 months straight line

Other plant and lab equipment

36 and 84 months straight line

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Trademarks and patents

120 months straight line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Unlisted investments are measured at cost, less any subsequent accumulated impairment losses, unless fair value can be measured reliably.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the group will not be able to collect all amounts due according to the original terms of the receivables.

Debtors receivable within one year
Debtors with no stated interest rate and receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Debtors receivable after more than one year
Debtors with no stated interest rate and receivable after more than one year are recorded at transaction price as a non-current asset. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the group does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.


Creditors payable within one year
Creditors with no stated interest rate and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Creditors payable after more than one year
Creditors with no stated interest rate and payable after more than one year are recorded at transaction price as a non-current liability. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
 

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the group has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Provisions

Provisions are recognised when the group has an obligation at the reporting date as a result of a past event, it is probable that the group will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. Equity-related direct costs are recognised in share premium reserve when incurred. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the group has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Share based payments

The cost and corresponding increase in equity in respect of equity-settled share-based payment transactions with employees are measured by references to the fair value of the equity instruments issued at the date of grant. Amounts are expensed on a straight line basis over the vesting period based on the estimate of shares that will eventually vest and adjusted for the effect of non-market based vesting conditions. The cost and fair value of the liability incurred in respect of cash-settled transactions is measured using an appropriate option pricing model with changes in fair value recognised in the profit and loss for the period.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

3

Turnover

The analysis of the group's Turnover for the year from continuing operations is as follows:

2024
£

2023
£

Sale of goods

4,999,722

5,331,885

Grant income

335,950

338,174

5,335,672

5,670,059

4

Operating loss

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

881,532

957,956

Amortisation expense

7,080

7,080

Research and development cost

129,408

80,067

Profit on disposal of property, plant and equipment

(8,818)

(8,935)

5

Other interest receivable and similar income

2024
£

2023
£

Interest income on bank deposits

90,208

118,052

6

Interest payable and similar expenses

2024
£

2023
£

Interest on bank overdrafts and borrowings

2,431

2,814

Interest expense on other finance liabilities

78,667

15,064

Foreign exchange losses

65,359

60,975

146,457

78,853

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

7

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2024
£

2023
£

Wages and salaries

7,124,503

7,023,663

Social security costs

752,264

805,166

Other short-term employee benefits

19,918

3,099

Pension costs, defined contribution scheme

409,170

139,030

Director final salary compensation

-

370,231

Other employee expense

596,048

256,753

8,901,903

8,597,942

The average number of persons employed by the group (including directors) during the year, analysed by category was as follows:

2024
No.

2023
No.

Production

53

49

Administration and support

14

28

Research and development

36

22

Sales, marketing and distribution

24

23

Other departments

6

18

133

140

8

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

376,284

585,160

Contributions paid to defined contribution schemes

29,808

4,291

Director final salary compensation

-

370,231

406,092

959,682

The director final salary compensation relates to the departure of Katie Critchlow as CEO and director. Katie departed the Company on 27 July 2023 and received a compensation package as per the settlement agreement.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

During the year the number of directors who were receiving benefits and share incentives was as follows:

2024
No.

2023
No.

Received or were entitled to receive shares under long term incentive schemes

3

2

Exercised share options

-

1

Accruing benefits under defined benefit pension scheme

-

-

Accruing benefits under defined contribution pension scheme

3

3

9

Auditors' remuneration

2024
£

2023
£

Audit of these financial statements

11,000

9,000

Other fees to auditors

The auditing of accounts of subsidiaries of the company

13,711

13,511

All other non-audit services

49,809

37,926

63,520

51,437


 

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

10

Taxation

Tax charged/(credited) in the consolidated profit and loss account

2024
£

2023
£

Current taxation

UK corporation tax

(383,439)

(201,789)

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2023 - higher than the standard rate of corporation tax in the UK) of 25% (2023 - 19%).

The differences are reconciled below:

2024
£

2023
£

Loss before tax

(9,674,610)

(9,218,277)

Corporation tax at standard rate

(2,418,653)

(2,166,295)

(Decrease)/increase in UK and foreign current tax from adjustment for prior periods

(63,406)

53,005

Tax increase from effect of capital allowances and depreciation

90,675

100,220

Effect of expense not deductible in determining taxable profit (tax loss)

96,908

4,293

Effect of tax losses utilised and/or carried forward to future periods

2,329,727

2,211,106

Tax decrease from effect of exercise of employee share options

(45,718)

(145,715)

Tax decrease relating to research and development tax credit

(372,972)

(258,403)

Total tax credit

(383,439)

(201,789)

The tax credit relates to a Research & Development Tax Credit claim. Management considers the R&D claim to not only include direct consumables, recorded as Research & Development costs in the Profit and Loss Account but also a proportion of staff labour. In 2024, the amount of staff labour attributed to R&D was £1,897,155 (2023: £1,156,309).

As at 31 December 2024, the company had unutilised tax losses totalling £25,475,305 (2023: £18,872,797) which may be offset against future trading profits, reducing the tax charge in later years.

A deferred tax asset of £6,209,788 has not been recognised on these losses due to uncertainty as to the timing of its receipt.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

11

Intangible assets

Group

Trademarks, patents and licenses
 £

Total
£

Cost or valuation

At 1 January 2024

70,801

70,801

At 31 December 2024

70,801

70,801

Amortisation

At 1 January 2024

11,980

11,980

Amortisation charge

7,080

7,080

At 31 December 2024

19,060

19,060

Carrying amount

At 31 December 2024

51,741

51,741

At 31 December 2023

58,821

58,821

Company

Trademarks, patents and licenses
 £

Total
£

Cost or valuation

At 1 January 2024

70,801

70,801

At 31 December 2024

70,801

70,801

Amortisation

At 1 January 2024

11,980

11,980

Amortisation charge

7,080

7,080

At 31 December 2024

19,060

19,060

Carrying amount

At 31 December 2024

51,741

51,741

At 31 December 2023

58,821

58,821

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

12

Tangible assets

Group

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2024

2,601,360

1,367,735

3,969,095

Additions

24,889

74,924

99,813

Disposals

(54,247)

(35,277)

(89,524)

At 31 December 2024

2,572,002

1,407,382

3,979,384

Depreciation

At 1 January 2024

1,120,850

884,307

2,005,157

Charge for the year

534,025

347,507

881,532

Eliminated on disposal

(50,725)

(35,277)

(86,002)

At 31 December 2024

1,604,150

1,196,537

2,800,687

Carrying amount

At 31 December 2024

967,852

210,845

1,178,697

At 31 December 2023

1,507,229

483,428

1,990,657


Assets held under finance lease or hire purchase

Total assets held under finance leases or hire purchase agreements had a net book value at 31 December 2024 totalling £89,091 (2023: £178,204).

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Company

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2024

1,234,001

1,367,735

2,601,736

Additions

24,888

74,924

99,812

Disposals

(41,582)

(35,277)

(76,859)

At 31 December 2024

1,217,307

1,407,382

2,624,689

Depreciation

At 1 January 2024

467,908

884,307

1,352,215

Charge for the year

168,543

347,507

516,050

Eliminated on disposal

(41,582)

(35,277)

(76,859)

At 31 December 2024

594,869

1,196,537

1,791,406

Carrying amount

At 31 December 2024

622,438

210,845

833,283

At 31 December 2023

766,093

483,428

1,249,521


Assets held under finance lease or hire purchase

Total assets held under finance leases or hire purchase agreements had a net book value at 31 December 2024 totalling £89,091 (2023: £178,204).

13

Investments

Company

2024
£

2023
£

Investments in subsidiaries

1

1

Subsidiaries

£

Cost or valuation

At 1 January 2024

1

Provision

Carrying amount

At 31 December 2024

1

At 31 December 2023

1

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2024

2023

Subsidiary undertakings

Nature Metrics North America Ltd

590 Hanlon Creek, Unit 11, Guelph, Ontario, N1C 0A1, Canada

Ordinary shares

100%

100%

Subsidiary undertakings

Nature Metrics North America Ltd

The principal activity of Nature Metrics North America Ltd is envinronmental consulting and biotechnology research and development.

14

Other financial assets

Group

Financial assets
£

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2024

186,138

186,138

At 31 December 2024

186,138

186,138

Carrying amount

At 31 December 2024

186,138

186,138

Financial assets represents a minority shareholding in NatureSpace Partnership Limited, a UK registered private limited company (registration no. 10755017).
 

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Company

Financial assets
£

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2024

186,138

186,138

At 31 December 2024

186,138

186,138

Carrying amount

At 31 December 2024

186,138

186,138

Financial assets represents a minority shareholding in NatureSpace Partnership Limited, a UK registered private limited company (registration no. 10755017).

15

Stocks

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Inventory

430,262

612,125

399,645

528,299

16

Debtors

   

Group

Company

Note

2024
£

2023
£

2024
£

2023
£

Trade debtors

 

1,170,737

1,969,611

826,520

1,729,712

Amounts owed by related parties

-

-

2,834,852

2,539,888

Other debtors

 

62,715

6,000

126,228

6,074

Prepayments

 

236,618

160,010

228,046

113,133

Accrued income

 

136,430

80,821

136,430

80,821

Corporation tax asset

10

770,204

578,618

770,204

578,618

   

2,376,704

2,795,060

4,922,280

5,048,246


 

 

Group

Company

Non-current

2024
£

2023
£

2024
£

2023
£

Rent deposit

155,672

159,777

155,672

159,777

 

155,672

159,777

155,672

159,777

The rental deposit of £155,672 (2023: £159,777) is deemed a debtor due after more than one year, as the rental agreement expires in 2031 with a break clause available to the Company in 2026.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

17

Cash and cash equivalents

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Cash at bank

3,102,367

7,505,506

2,970,920

7,429,076

18

Creditors

   

Group

Company

Note

2024
£

2023
£

2024
£

2023
£

Due within one year

 

Loans and borrowings

19

3,575,825

147,983

3,575,825

147,983

Trade creditors

 

546,635

716,812

532,199

676,247

Social security and other taxes

 

186,188

267,847

178,876

226,745

Outstanding pension costs

 

-

88,200

-

88,200

Other payables

 

28,871

18,395

20,665

9,852

Accruals

 

730,496

471,109

714,776

450,580

Rent inducement

 

192,500

222,500

192,500

222,500

Deferred income

 

1,453,989

1,500,531

1,310,067

1,414,526

 

6,714,504

3,433,377

6,524,908

3,236,633

19

Loans and borrowings

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Current loans and borrowings

Bank borrowings

-

7,310

-

7,310

HP and finance lease liabilities

3,714

140,673

3,714

140,673

Convertible debt

3,572,111

-

3,572,111

-

3,575,825

147,983

3,575,825

147,983

Bank borrowings represents an unsecured loan obtained through the Coronavirus Business Interruption Loan Scheme (CBILS), which incurred interest of 14.03% per annum. During the year, the loan was repaid in full.

HP liabilities includes one short term agreement, for the financing of office equipment and is repaid in full by January 2025.

During the year, the Company resolved to create and authorise the issue of up to £6,500,000 unsecured convertible loan notes, and as at 31 December 2024, £3,500,000 notes had been issued to the initial noteholders. The loan notes are interest bearing at a rate of 8% per annum, and as at 31 December 2024 interest accrued totalled £72,111.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

20

Obligations under leases and hire purchase contracts

Group

Operating leases

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

529,893

361,996

Later than one year and not later than five years

1,211,200

1,273,436

Later than five years

418,942

721,742

2,160,035

2,357,174

These operating leases relate to rental and equipment leases . The amount of non-cancellable operating lease payments recognised as an expense during the year was £361,966 (2023 - £368,658).

Company

Operating leases

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

470,914

302,483

Later than one year and not later than five years

1,211,200

1,210,373

Later than five years

418,942

721,742

2,101,056

2,234,598

These operating leases relates to rental and equipment leases. The amount of non-cancellable operating lease payments recognised as an expense during the year was £302,483 (2023 - £302,290).

21

Provisions for liabilities

Group

Other provisions
£

Total
£

At 1 January 2024

274,256

274,256

At 31 December 2024

274,256

274,256

The provision of £274,256 relates to a dilapidation provision. This represents the present value of the cost required to restore the office to its original state at the end of the lease as per the rental agreement.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Company

Other provisions
£

Total
£

At 1 January 2024

274,256

274,256

At 31 December 2024

274,256

274,256

The provision of £274,256 relates to a dilapidation provision. This represents the present value of the cost required to restore the office to its original state at the end of the lease as per the rental agreement.

There remains an uncertainty in both the timing and amount of the outflows. Since the outflows will occur upon departure of the office, it is not certain when this will occur and what the cost will be to restore the office to its original state.

22

Pension and other schemes

Defined contribution pension scheme

The group operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the group to the scheme and amounted to £409,170 (2023 - £139,030).

Contributions totalling £Nil (2023 - £88,200) were payable to the scheme at the end of the year and are included in creditors.

23

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £0.000001 each

1,980,215

1.98

1,943,115

1.94

Series A shares of £0.000001 each

901,121

.90

901,121

.90

Series A-1 shares of £0.000001 each

4,286,417

4.29

3,849,417

3.85

 

7,167,753

7.17

6,693,653

6.69

During the year 37,100 Ordinary shares having an aggregate nominal value of £0.04 were allotted for an aggregate consideration of £16,139. 437,000 Series A-1 shares having an aggregate nominal value of £0.44 were also allotted for an aggregate consideration of £4,370.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

24

Other reserves

Other reserves represents the cumulative amounts charged to profit in respect of employee share option arrangements that have not yet been settled by awarding shares to individuals, and its purpose is to ensure that the financial statements accurately reflect the impact of share-based compensation on the company's equity. Once employee share option arrangements are settled via the allotment of shares, the cumulative amounts charged to profit in respect of these shares is transferred to retained earnings.

25

Share-based payments

Scheme details and movements

The Company has a share option scheme for certain employees. The total number of employees of the Company that share options have been granted to is 28 (2023: 11). In certain circumstances the options may lapse if the relevant individual ceases to be an employee of the Company.

The movements in the number of share options during the year were as follows:

2024
Number

2023
Number

Outstanding, start of period

354,666

571,566

Granted during the period

555,864

-

Exercised during the period

(37,100)

(178,201)

Expired during the period

(88,932)

(38,699)

Outstanding, end of period

784,498

354,666

The movements in the weighted average exercise price of share options during the year were as follows:

2024
£

2023
£

Outstanding, start of period

3.18

2.93

Granted during the period

2.32

-

Exercised during the period

(0.43)

0.43

Expired during the period

(2.77)

(0.18)

Outstanding, end of period

2.30

3.18

Options are generally exercisable at a price equal to the estimated fair value of the Company's shares on the date of grant. The vesting period is three years. If the options remain unexercised after a period of 10 years from the date of grant, the options expire.

The fair value of the share options at the grant date was calculated using the Black Scholes model, which is considered to be the most appropriate generally accepted valuation method of measuring fair value.

Effect of share-based payments on profit or loss and financial position

The total expense recognised in profit or loss for the year was £387,613 (2023 - £17,949).

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

26

Post balance sheet events

Subsequent to 31 December 2024, the Group received £16,499,992 in relation to a funding raise signed in December 2024.
 

27

Control

There is no controlling party.

 

Nature Metrics Limited

Detailed Consolidated Profit and Loss Account for the Year Ended 31 December 2024

2024
£

2023
£

Turnover (analysed below)

5,335,672

5,670,059

Cost of sales (analysed below)

(2,626,842)

(3,044,602)

Gross profit

2,708,830

2,625,457

Gross profit (%)

50.77%

46.3%

Administrative expenses

Employment costs (analysed below)

(7,844,640)

(7,034,224)

Establishment costs (analysed below)

(753,703)

(648,225)

General administrative expenses (analysed below)

(2,920,459)

(3,288,502)

Finance charges (analysed below)

(6,625)

(9,943)

Depreciation costs (analysed below)

(888,612)

(965,036)

Other expenses (analysed below)

8,818

8,935

(12,405,221)

(11,936,995)

Other operating income (analysed below)

78,030

54,062

Operating loss

(9,618,361)

(9,257,476)

Other interest receivable and similar income (analysed below)

90,208

118,052

Interest payable and similar expenses (analysed below)

(146,457)

(78,853)

(56,249)

39,199

Loss before tax

(9,674,610)

(9,218,277)

 

Nature Metrics Limited

Detailed Consolidated Profit and Loss Account for the Year Ended 31 December 2024

2024
£

2023
£

   

Turnover

Sale of goods

4,999,722

5,331,885

Other revenue

335,950

338,174

5,335,672

5,670,059

   

Cost of sales

Opening raw materials

(528,299)

(397,264)

Materials

(17,788)

(34,518)

Purchases

(1,190,448)

(1,341,140)

Direct costs

(232,689)

(236,261)

Closing raw materials

399,645

528,299

Wages and salaries (excluding directors)

(1,057,263)

(1,563,718)

(2,626,842)

(3,044,602)

   

Employment costs

Wages and salaries (excluding directors)

(5,690,956)

(4,874,785)

Staff NIC (Employers)

(752,264)

(805,166)

Directors remuneration

(376,284)

(585,160)

Staff pensions (Defined contribution)

(379,362)

(134,739)

Directors pensions (Defined contribution)

(29,808)

(4,291)

Private health insurance

(19,918)

(3,099)

Casual wages

(81,113)

(109,772)

Staff training

(127,322)

(129,032)

Share option charge

(387,613)

(17,949)

Final salary payment

-

(370,231)

(7,844,640)

(7,034,224)

   

Establishment costs

Rent and rates

(610,475)

(523,804)

Light, heat and power

(83,435)

(80,046)

Insurance

(59,793)

(44,375)

(753,703)

(648,225)

   

General administrative expenses

Repairs and maintenance

(28,761)

(198,076)

Telephone and fax

(24,881)

(26,809)

Office expenses

(82,696)

(167,937)

Computer software and maintenance costs

(748,488)

(973,672)

Printing, postage and stationery

(1,426)

(6,616)

Charitable donations

(57)

-

Research and development

(129,408)

(80,067)

 

Nature Metrics Limited

Detailed Consolidated Profit and Loss Account for the Year Ended 31 December 2024

2024
£

2023
£

   

Travel and subsistence

(294,723)

(250,157)

Advertising

(216,499)

(255,128)

Staff entertaining (allowable for tax)

(6,776)

(4,917)

Auditor's remuneration - The audit of the company's annual accounts

(11,000)

(9,000)

Auditor's remuneration - associate companies

(13,711)

(13,511)

Auditors' remuneration - non audit work

(49,809)

(37,926)

Consultancy fees

(955,475)

(1,160,314)

Legal and professional fees

(329,267)

(95,627)

Bad debts written off

(27,482)

(8,745)

(2,920,459)

(3,288,502)

   

Finance charges

Bank charges

(6,625)

(9,943)

   

Depreciation costs

Amortisation of patents

(7,080)

(7,080)

Depreciation of plant and machinery (owned)

(502,397)

(382,194)

Depreciation of office equipment (owned)

(379,135)

(575,762)

(888,612)

(965,036)

   

Other expenses

Profit/(loss) on disposal of tangible fixed assets

8,818

8,935

   

Other operating income

Other operating income

78,030

54,062

   

   

Other interest receivable and similar income

Bank interest receivable

90,208

118,052

   

Interest payable and similar expenses

Bank loan interest payable

(2,431)

(2,814)

Other loan interest

(78,546)

(15,064)

Other interest payable

(121)

-

Foreign currency gains/(losses)

(65,359)

(60,975)

(146,457)

(78,853)

 

Nature Metrics Limited

Detailed Company Profit and Loss Account for the Year Ended 31 December 2024

2024
£

2023
£

Turnover (analysed below)

4,591,593

5,157,497

Cost of sales (analysed below)

(2,476,095)

(2,717,557)

Gross profit

2,115,498

2,439,940

Gross profit (%)

46.07%

47.31%

Administrative expenses

Employment costs (analysed below)

(7,247,645)

(6,595,262)

Establishment costs (analysed below)

(656,632)

(550,034)

General administrative expenses (analysed below)

(2,751,288)

(3,147,887)

Finance charges (analysed below)

(4,025)

(4,904)

Depreciation costs (analysed below)

(523,130)

(585,695)

(11,182,720)

(10,883,782)

Other operating income (analysed below)

78,030

54,062

Operating loss

(8,989,192)

(8,389,780)

Other interest receivable and similar income (analysed below)

90,208

118,052

Interest payable and similar expenses (analysed below)

(96,470)

(77,878)

(6,262)

40,174

Loss before tax

(8,995,454)

(8,349,606)

 

Nature Metrics Limited

Detailed Company Profit and Loss Account for the Year Ended 31 December 2024

2024
£

2023
£

   

Turnover

Sale of goods

4,302,837

4,819,323

Other revenue

288,756

338,174

4,591,593

5,157,497

   

Cost of sales

Opening raw materials

(528,299)

(397,265)

Materials

(17,788)

(34,518)

Purchases

(1,044,556)

(1,378,000)

Direct costs

(228,034)

(83,641)

Closing raw materials

399,645

528,299

Wages and salaries (excluding directors)

(1,057,063)

(1,352,432)

(2,476,095)

(2,717,557)

   

Employment costs

Wages and salaries (excluding directors)

(5,152,973)

(4,435,823)

Staff NIC (Employers)

(741,514)

(805,166)

Directors remuneration

(376,283)

(585,160)

Staff pensions (Defined contribution)

(383,902)

(139,030)

Private health insurance

(1,212)

(3,099)

Casual wages

(81,112)

(109,773)

Staff training

(123,036)

(129,031)

Share option charge

(387,613)

(17,949)

Final salary payment

-

(370,231)

(7,247,645)

(6,595,262)

   

Establishment costs

Rent

(528,635)

(443,484)

Light, heat and power

(73,299)

(67,136)

Insurance

(54,698)

(39,414)

(656,632)

(550,034)

   

General administrative expenses

Repairs and maintenance

(10,046)

(186,121)

Telephone and fax

(21,627)

(24,648)

Office expenses

(78,377)

(156,497)

Computer software and maintenance costs

(742,647)

(957,346)

Printing, postage and stationery

(1,311)

(4,676)

Research and development

(114,612)

(52,023)

Travel and subsistence

(266,320)

(227,749)

Advertising

(197,946)

(225,763)

 

Nature Metrics Limited

Detailed Company Profit and Loss Account for the Year Ended 31 December 2024

2024
£

2023
£

   

Staff entertaining (allowable for tax)

(5,708)

(4,343)

Auditor's remuneration - The audit of the company's annual accounts

(11,000)

(9,000)

Auditors' remuneration - non audit work

(49,810)

(37,927)

Consultancy fees

(938,382)

(1,160,313)

Legal and professional fees

(313,332)

(92,736)

Bad debts written off

(170)

(8,745)

(2,751,288)

(3,147,887)

   

Finance charges

Bank charges

(4,025)

(4,904)

   

Depreciation costs

Amortisation of patents

(7,080)

(7,080)

Depreciation of plant and machinery (owned)

(347,506)

(382,193)

Depreciation of office equipment (owned)

(168,544)

(196,422)

(523,130)

(585,695)

   

Other operating income

Other operating income

78,030

54,062

   

   

Other interest receivable and similar income

Bank interest receivable

90,208

117,141

Other interest receivable

-

911

90,208

118,052

   

Interest payable and similar expenses

Bank loan interest payable

(2,431)

(2,804)

Other loan interest

(78,546)

(15,064)

Penalties and fines

-

(874)

Other interest payable

(121)

-

Foreign currency gains/(losses)

(15,372)

(59,136)

(96,470)

(77,878)